Welcome to LookChem.com Sign In|Join Free

CAS

  • or

880175-36-0

C20H23ClN8O2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

880175-36-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 880175-36-0 Structure

  • Basic information

    1. Product Name: C20H23ClN8O2
    2. Synonyms: C20H23ClN8O2
    3. CAS NO:880175-36-0
    4. Molecular Formula:
    5. Molecular Weight: 442.908
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 880175-36-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C20H23ClN8O2(CAS DataBase Reference)
    10. NIST Chemistry Reference: C20H23ClN8O2(880175-36-0)
    11. EPA Substance Registry System: C20H23ClN8O2(880175-36-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 880175-36-0(Hazardous Substances Data)

880175-36-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 880175-36-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,0,1,7 and 5 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 880175-36:
(8*8)+(7*8)+(6*0)+(5*1)+(4*7)+(3*5)+(2*3)+(1*6)=180
180 % 10 = 0
So 880175-36-0 is a valid CAS Registry Number.

880175-36-0Downstream Products

880175-36-0Relevant articles and documents

Diaminotriazole compounds useful as protein kinase inhibitors

-

Page/Page column 74; 77, (2010/10/20)

The present invention relates to inhibitors of protein kinases, particularly to inhibitors of JAK2 and JAK3. The invention also provides pharmaceutical compositions comprising the compounds of the invention, processes for preparing the compounds and methods of using the compositions in the treatment of various disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 880175-36-0